350484 <common-name>3-[[1-[4-[[2-[(5-carbamoyl-2-methylphenyl)diazenyl]-3-oxobutanoyl]amino]-3-chloroanilino]-1,3-dioxobutan-2-yl]diazenyl]-4-methylbenzamide</common-name> <description>3-[[1-[4-[[2-[(5-carbamoyl-2-methylphenyl)diazenyl]-3-oxobutanoyl]amino]-3-chloroanilino]-1,3-dioxobutan-2-yl]diazenyl]-4-methylbenzamide is a chemical compound with the formula C30H29ClN8O6. With an average molecular weight of 633.10 g/mol, 3-[[1-[4-[[2-[(5-carbamoyl-2-methylphenyl)diazenyl]-3-oxobutanoyl]amino]-3-chloroanilino]-1,3-dioxobutan-2-yl]diazenyl]-4-methylbenzamide is a heavy molecule.</description> <cas>253430-12-5</cas> <pubchem-id>101195507</pubchem-id> <chemical-formula>C30H29ClN8O6</chemical-formula> <weight>633.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:35:00Z</created-at> <updated-at type="dateTime">2026-08-31T15:35:00Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=C(C=C(C=C1)C(=O)N)N=NC(C(=O)C)C(=O)NC2=CC(=C(C=C2)NC(=O)C(C(=O)C)N=NC3=C(C=CC(=C3)C(=O)N)C)Cl</moldb-smiles> <moldb-formula>C30H29ClN8O6</moldb-formula> <moldb-inchi>InChI=1S/C30H29ClN8O6/c1-14-5-7-18(27(32)42)11-23(14)36-38-25(16(3)40)29(44)34-20-9-10-22(21(31)13-20)35-30(45)26(17(4)41)39-37-24-12-19(28(33)43)8-6-15(24)2/h5-13,25-26H,1-4H3,(H2,32,42)(H2,33,43)(H,34,44)(H,35,45)</moldb-inchi> <moldb-inchikey>MSSSLKGZMRFNHM-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">632.1898584</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346377</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>3-[[1-[4-[[2-[(5-carbamoyl-2-methylphenyl)diazenyl]-3-oxobutanoyl]amino]-3-chloroanilino]-1,3-dioxobutan-2-yl]diazenyl]-4-methylbenzamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300789</sync-id> <structure-inchikey>MSSSLKGZMRFNHM-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40402000000000000000000000000000024800000000008100000000000000000000800000000400000000000002000020001000000000000000000000000000000000000000400400000000000000000020000000000000000004000000000000000000010000000010080000100080000000001000000000000000000000400000000040000000000000000000000080001000000000000080000000000000040000002000000000000000084100000800000000000000000000000000000000000000000400000000000100000000800010104200002100000200000000000000008000000000840040800000000400000000000000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAtAAAALwAAAIABBgBgAAAAAQMGQCgAAAAD BAZAKAAAAAMEBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEG ACgAAAADBAgAKAAAAAMCBwBoAAAAAwECBwAoAAAAAwMHACgAAAADAwYAYAAA AAMBBgAoAAAAAwQIACgAAAADAgYAYAAAAAEDBgAoAAAAAwQIACgAAAADAgcA aAAAAAMCAQZAKAAAAAMEBkBoAAAAAwMBBkAoAAAAAwQGQCgAAAADBAZAaAAA AAMDAQZAaAAAAAMDAQcAaAAAAAMCAQYAKAAAAAMECAAoAAAAAwIGAGAAAAAD AQYAKAAAAAMECAAoAAAAAwIGAGAAAAABAwcAKAAAAAMDBwAoAAAAAwMGQCgA AAADBAZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAAD AwEGACgAAAADBAgAKAAAAAMCBwBoAAAAAwECBgBgAAAAAQMRACAAAAABCwAB AAECaAwCA2gMAwRoDAQFaAwFBmgMBAcgBwgoAgcJIAIKIAoLKAILDAAMDQAN DggCDQ8ADBAAEBEoAhASIBITIBMUaAwUFWgMFRZoDBYXaAwXGGgMFhkgGRog GhsoAhocABwdAB0eCAIdHwAcIAAgISgCISIgIiNoDCMkaAwkJWgMJSZoDCYn aAwmKCAoKSgCKCogIysAFSwABgFoDBgTaAwnImgMQgMAAAAGAQYFBAMCBhQV FhcYEwYjJCUmJyIXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:28Z</structure-indexed-at> </compound>